Koyfin Home > Directory > Health Care > Akebia Therapeutics > Price / Tangible Book Value

Akebia Therapeutics Price / Tangible Book Value Chart (AKBA)

Akebia Therapeutics annual/quarterly Price / Tangible Book Value from 2014 to 2020.
  • Akebia Therapeutics Price / Tangible Book Value for the quarter ending October 10, 2020 was 2.58 a -16.02% decrease of -0.41 year over year
  • Akebia Therapeutics Price / Tangible Book Value for the last 12 months ending October 10, 2020 was 2.58 a -16.02% decrease of -0.41 year over year
  • Akebia Therapeutics Annual Price / Tangible Book Value for 2020 was 2.58 a -11.97% decrease of -0.31 from 2019
  • Akebia Therapeutics Annual Price / Tangible Book Value for 2020 was 2.89 a -3.14% decrease of -0.09 from 2019
  • Akebia Therapeutics Annual Price / Tangible Book Value for 2020 was 2.98 a -0.46% decrease of -0.01 from 2019
Other Valuation Metrics:
  • Akebia Therapeutics Market Cap for the quarter ending March 03, 2018 was $535m a -24.92% decrease of -133m year over year
  • Akebia Therapeutics Price / Book for the quarter ending March 03, 2018 was 3.80 a -378.76% decrease of -14.40 year over year
  • Akebia Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $217m a -91.84% decrease of -199m year over year
View Chart On Koyfin

Quarterly AKBA Price / Tangible Book Value Data

10/20202.58
10/20202.89
10/20202.98
10/20202.99
10/20203.25
10/20203.36
10/20203.43
10/20203.32
10/20203.25
10/20203.22

Annual AKBA Price / Tangible Book Value Data

20202.58
20202.89
20202.98
20202.99
20203.25
20203.36
20203.43
20203.32
20203.25
20203.22